✦ LIBER ✦

Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

✍ Scribed by Homma, Yuki; Taniguchi, Koichi; Murakami, Takashi; Nakagawa, Kazuya; Nakazawa, Masatoshi; Matsuyama, Ryusei; Mori, Ryutaro; Takeda, Kazuhisa; Ueda, Michio; Ichikawa, Yasushi; Tanaka, Kuniya; Endo, Itaru

Book ID: 121547176
Publisher: Springer
Year: 2013
Tongue: English
Weight: 375 KB
Volume: 21
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-013-3390-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemoradiotherapy with S-1 i

Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer

✍ Shimizu, Dai; Fujii, Tsutomu; Hattori, Masashi; Suenaga, Masaya; Yamada, Suguru; 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 50 KB

Gemcitabine based neoadjuvant chemoradio

Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer

✍ Cho, In Rae; Chung, Moon Jae; Bang, Seungmin; Park, Seung Woo; Chung, Jae Bock; 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 362 KB

Neoadjuvant Therapy for Achieving Margin

Neoadjuvant Therapy for Achieving Margin Negative Resection in Borderline Resectable Pancreatic Ductal Adenocarcinoma

✍ Chandrasekaran, S.; Coveler, A.L.; Chandrasekaran, S.; Lucas, F.R.; Patel, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Neoadjuvant chemoradiotherapy with S-1 i

Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer with involvement of the major artery

✍ Suenaga, M.; Fujii, T.; Yamada, S.; Okumura, N.; Kobayashi, D.; Tanaka, C.; Naka 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 46 KB

Management of Borderline Resectable Panc

Management of Borderline Resectable Pancreatic Adenocarcinoma With Neoadjuvant GTX Chemotherapy Followed by Combined Chemoradiation

✍ Horowitz, D.P.; Ebiana, V.; Gidea-Addeo, D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Maximizing the Effect of Neoadjuvant Che

Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer

✍ D.M. Sopka; Y.S. Chun; S.J. Cohen; F. Zhu; B.N. Milestone; H.S. Cooper; G.M. Fre 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB